ACCE-话题@MedSci - 梅斯（MedSci）

#ACCE#

30篇内容 | 1155人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1778928, encodeId=c8d11e78928fe, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=开放获取Open Access的各种类型, objectType=article, longId=301408, objectId=983230140819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=983230140819, replyNumber=0, likeNumber=85, createdTime=2022-07-13, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=983230140819, moduleTitle=开放获取Open Access的各种类型, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=983230140819)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778926, encodeId=e5d41e78926de, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Graphpad Prism中 format access从哪里进去？, objectType=article, longId=215555, objectId=438c21555571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438c21555571, replyNumber=0, likeNumber=61, createdTime=2021-10-27, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438c21555571, moduleTitle=Graphpad Prism中 format access从哪里进去？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=438c21555571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779303, encodeId=51081e79303ff, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域, objectType=article, longId=217964, objectId=9dba21e96483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dba21e96483, replyNumber=0, likeNumber=72, createdTime=2022-06-23, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dba21e96483, moduleTitle=默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9dba21e96483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779304, encodeId=288d1e79304be, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=开放获取Open Access的各种类型, objectType=article, longId=301408, objectId=983230140819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=983230140819, replyNumber=0, likeNumber=88, createdTime=2022-09-30, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=983230140819, moduleTitle=开放获取Open Access的各种类型, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=983230140819)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778927, encodeId=6c561e7892722, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域, objectType=article, longId=217964, objectId=9dba21e96483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dba21e96483, replyNumber=0, likeNumber=74, createdTime=2022-06-21, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dba21e96483, moduleTitle=默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9dba21e96483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779301, encodeId=e74d1e7930180, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球, objectType=article, longId=201743, objectId=29d4201e4375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29d4201e4375, replyNumber=0, likeNumber=61, createdTime=2021-08-19, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29d4201e4375, moduleTitle=洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29d4201e4375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779302, encodeId=cb221e793023b, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Graphpad Prism中 format access从哪里进去？, objectType=article, longId=215555, objectId=438c21555571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438c21555571, replyNumber=0, likeNumber=76, createdTime=2021-10-21, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438c21555571, moduleTitle=Graphpad Prism中 format access从哪里进去？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=438c21555571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778925, encodeId=a80d1e78925ad, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球, objectType=article, longId=201743, objectId=29d4201e4375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29d4201e4375, replyNumber=0, likeNumber=72, createdTime=2021-05-06, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29d4201e4375, moduleTitle=洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29d4201e4375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779300, encodeId=a96f1e793009b, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号, objectType=article, longId=193600, objectId=d0bf193600be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0bf193600be, replyNumber=0, likeNumber=52, createdTime=2021-03-13, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0bf193600be, moduleTitle=Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d0bf193600be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778924, encodeId=b8ca1e789241b, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号, objectType=article, longId=193600, objectId=d0bf193600be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0bf193600be, replyNumber=0, likeNumber=70, createdTime=2020-10-21, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0bf193600be, moduleTitle=Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d0bf193600be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779299, encodeId=4e761e792991e, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, objectType=article, longId=128054, objectId=039a12805491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039a12805491, replyNumber=0, likeNumber=80, createdTime=2018-09-17, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039a12805491, moduleTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=039a12805491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778922, encodeId=33e11e78922ee, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似, objectType=article, longId=127715, objectId=151412e7154d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=151412e7154d, replyNumber=0, likeNumber=76, createdTime=2018-01-25, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=151412e7154d, moduleTitle=高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=151412e7154d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779297, encodeId=c38c1e7929731, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, objectType=article, longId=120699, objectId=0ade1206998f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ade1206998f, replyNumber=0, likeNumber=72, createdTime=2018-10-30, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ade1206998f, moduleTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ade1206998f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779298, encodeId=a0ee1e7929861, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似, objectType=article, longId=127715, objectId=151412e7154d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=151412e7154d, replyNumber=0, likeNumber=72, createdTime=2018-03-31, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=151412e7154d, moduleTitle=高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=151412e7154d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779295, encodeId=84651e79295ea, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官, objectType=article, longId=107024, objectId=d61610e02407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d61610e02407, replyNumber=0, likeNumber=73, createdTime=2017-12-11, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d61610e02407, moduleTitle=OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d61610e02407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778923, encodeId=abc91e7892304, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, objectType=article, longId=128054, objectId=039a12805491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039a12805491, replyNumber=0, likeNumber=90, createdTime=2018-07-22, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039a12805491, moduleTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=039a12805491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779296, encodeId=22d11e79296a7, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Borderless Access推出用于医疗保健研究的编程采样组件HealthSight, objectType=article, longId=112580, objectId=b28d112580f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b28d112580f9, replyNumber=0, likeNumber=84, createdTime=2018-03-05, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b28d112580f9, moduleTitle=Borderless Access推出用于医疗保健研究的编程采样组件HealthSight, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b28d112580f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778921, encodeId=91cb1e789214a, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, objectType=article, longId=120699, objectId=0ade1206998f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ade1206998f, replyNumber=0, likeNumber=92, createdTime=2018-04-04, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ade1206998f, moduleTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ade1206998f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778919, encodeId=d6531e7891947, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官, objectType=article, longId=107024, objectId=d61610e02407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d61610e02407, replyNumber=0, likeNumber=75, createdTime=2017-09-26, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d61610e02407, moduleTitle=OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d61610e02407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778920, encodeId=285a1e7892067, content=<a href='/topic/show?id=a068181685' target=_blank style='color:#2F92EE;'>#ACCE#</a>, objectTitle=Borderless Access推出用于医疗保健研究的编程采样组件HealthSight, objectType=article, longId=112580, objectId=b28d112580f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b28d112580f9, replyNumber=0, likeNumber=78, createdTime=2017-11-04, rootId=0, userName=hxj0117, userId=ac59108, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b28d112580f9, moduleTitle=Borderless Access推出用于医疗保健研究的编程采样组件HealthSight, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b28d112580f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACCE

2020-05-29

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

开放获取Open Access的各种类型

2022-07-13

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Graphpad Prism中 format access从哪里进去？

2021-10-27

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域

2022-06-23

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

开放获取Open Access的各种类型

2022-09-30

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

默沙东以110亿美元收购Accelron接近完成，押注呼吸和血液疾病领域

2022-06-21

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球

2021-08-19

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Graphpad Prism中 format access从哪里进去？

2021-10-21

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

洛克菲勒基金会、ACCESS Health发布权威报告，微医等中国经验被推向全球

2021-05-06

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号

2021-03-13

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Acceleron的TGF-β配体陷阱Sotatercept治疗肺动脉高压，获得欧洲药品管理局的优先药品（PRIME）称号

2020-10-21

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗

2018-09-17

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似

2018-01-25

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化

2018-10-30

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

高龄房颤患者合并ACS：二联与三联抗栓MACCE和死亡发生率相似

2018-03-31

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官

2017-12-11

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗

2018-07-22

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Borderless Access推出用于医疗保健研究的编程采样组件HealthSight

2018-03-05

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化

2018-04-04

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

OrthoAccel Technologies, Inc.任命大卫-约萨为首席执行官

2017-09-26

hxj0117 (审核中...)

前往app查看评论内容

#ACCE#

Borderless Access推出用于医疗保健研究的编程采样组件HealthSight

2017-11-04

科室
- - 订阅+
  - 更多科室
工具
服务